Pharma Intelligence відкриті
[search 0]
більше

Download the App!

show episodes
 
Loading …
show series
 
In this month’s podcast, Medtech Insight's Reed Miller discusses iRhythm’s CEO Quentin Blackford’s vision for the company as it plans for expanding its remote cardiac monitoring and arrythmia diagnostics market. Marion Webb highlights conversations with ORCHA’s clinical lead Fatima Ahmed on the shortfall of trustworthy femtech apps and with medical…
 
Pink Sheet reporter and editors discuss the first mark-up of the House FDA user fee bill, the likelihood of more postmarketing quality requirements for drug manufacturers, and the significance of the shrinking number of FDA advisory committee meetings.Informa
 
Sanjiv Navangul, managing director and CEO, Bharat Serums and Vaccines, outlines, in a wide ranging interview, the firm’s gameplan to establish itself as a “force to reckon with” in women’s health - it goes beyond drugs and encompasses devices and potentially digital therapeutics as well. The former Janssen India chief also weighs in on the worryin…
 
Pink Sheet reporter and editors and HBW Insight editor discuss FDA reforms in the new user fee reauthorization bill, additional industry inducements to market OTC naloxone, and the impact of a Supreme Court’s potential overturning of Roe v. Wade on the agency.Informa
 
In this episode, HBW Insight speaks to Michael Hufford, co-founder and CEO of Harm Reduction Therapeutics about the inaccessibility of naloxone, a life-saving opioid overdose antidote. Hufford unpacks on the history of naloxone access and explains why standing orders aren’t as helpful as they seem. We also explore the incentives for companies curre…
 
In this episode, HBW Insight chats with IQVIA Consumer Health’s Prisana Pitale about research the organisation has done on the recent self-care trends that will endure after COVID. Commissioning an external organisation to speak to industry leaders, Pitale points to wellness and prevention, Rx-to-OTC switch and naturals as drivers of long-term chan…
 
Pink Sheet reporter and editor discuss next steps in the development of COVID-19 vaccines for young children, complaints about CMS’s coverage decision for Aduhelm, and the congressional investigation of McKinsey’s FDA conflicts of interest.Informa
 
The CEO of Chinese biotech CANbridge talks to Scrip’s Brian Yang on a broad range of topics related to the company’s plans and strategy in this new series of audio interviews with senior biopharma executives in China.Informa
 
In this episode, HBW speaks to AI technology expert Sampo Parkkinen, CEO of Revieve. We discuss the importance of customization for businesses and consumers, the future of AI in the cosmetics industry, and the younger demographics that are most interested in brand personalization. Finally, we talk about Revieve’s space in the metaverse, and how bus…
 
Pink Sheet reporter and editors discuss CDC advisors’ views on COVID-19 vaccine booster policy, new FDA guidance to promote clinical trial diversity, and what some FDA employees are finding when they return to the White Oak headquarters.Informa
 
Zydus Lifesciences’ (formerly Cadila Healthcare) managing director Sharvil Patel speaks to Scrip on a host of topics ranging from a focus on rare diseases to a fresh corporate identity and plans for launch of a two-dose version of the world’s first plasmid DNA vaccine that it developed against COVID-19. Patel also talks about his personal business …
 
In this episode, HBW Insight editors look ahead to Q1 sales and earnings reports of the world’s largest consumer healthcare companies. We reflect on what has happened in the last 12 months during the COVID-19 pandemic, and what the next few months might bring for industry. The return of cough and cold, inflation and the war in Ukraine and OTC busin…
 
In this edition of Device Week, Medtech Insight’s Marion Webb reviews her recent interviews with Martha Shadan, the CEO of Miach Orthopedics, and Outset Medical’s CEO Leslie Trigg. Reed Miller has an update on Medtronic’s long-awaited renal denervation technology.Listen to the podcast via the player below:The archive of Medtech Insight's Device Wee…
 
In this month’s podcast, Medtech Insight's Reed Miller reports on Amazon’s new deal with North Carolina-Triangle company Thread Research to create decentralized clinical trials and HIMSS coverage. Marion Webb discusses highlights from her live coverage at the AAOS and Sensors Summit conferences.Medtech Insight articles addressing topics discussed i…
 
In this episode, HBW Insight takes a bird’s eye view of sustainability in the cosmetics industry with HBW Insight Executive Editor Ryan Nelson. We discuss the drivers of sustainability efforts such as consumer demand for more eco-friendly products and the growing social consciousness about climate. We also discuss what steps companies are taking to…
 
In this episode of Device Week: US lawmakers grilled FDA device center director Jeff Shuren on 30 March about the agency’s approach to putting together the latest user-fee agreement between industry and FDA.Medtech Insight articles addressing topics discussed in this episode:• FDA’s Shuren Grilled About Handling Of MDUFA V At House Hearing• Lifting…
 
Pink Sheet reporter and editors discuss lessons from the FDA’s advisory committee on Amylyx’s ALS drug, the FDA’s proposed FY 2023 budget surge, and the ongoing effort to change the CMS coverage decision on Aduhelm.Informa
 
In this episode, HBW Insight catches up with Association of the European Self-Care Industry, AESGP, director general Jurate Švarcaite to chat about the association’s upcoming Annual Meeting. The 58th Annual Meeting will be the first since the coronavirus pandemic that will take place in person, at the Hotel Meliá Castilla in Madrid, Spain, from the…
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D.For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Pink Sheet reporter and editors discuss a grassroots campaign against coverage of a controversial Alzheimer’s treatment, the potential for drug pricing reform, and the pandemic effects on FDA hiring and retention.Informa
 
In this episode of Speaking Of Medtech: Too often quality is overshadowed by regulatory and compliance, and some manufacturers view quality as an obstacle to getting product into the marketplace rather than a concept that will help a company save money, reputation, and patient lives.Medtech Insight articles addressing topics discussed in this episo…
 
Post-market surveillance requirements apply to all products under the Medical Device Regulation. But it is not just about compliance. Companies would do well to evaluate the additional benefits added PMS efforts can offer them, leading devices expert Bassil Akra explained during a recent interview with Medtech Insight. And he explained how small co…
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D. For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.Informa
 
In this episode, HBW Insight speaks to self-care marketing expert Stuart Mayell about the hottest trends in UK consumer health. Based on interviews with a variety of consumer health clients, Mayell – who is Head of Creative Difference at the Difference Collective – confirms many of the trends seen elsewhere, such as a need for health literacy as co…
 
Pink Sheet reporter and editors discuss new accelerated approval legislation, the changing FDA patient-focused drug development initiative, and the importance of access for COVID-19 treatments.Informa
 
In this edition of Device Week, Medtech Insight’s Reed Miller chats with UK-based reporter Barnaby Pickering about Zimmer Biomet’s recent spin-off of its spinal and dental businesses under the name ZimVie, and Marion Webb explains the emerging field of femtech, which includes innovations to treat often-overlooked needs in women’s health.Listen to t…
 
For MedTech Europe’s Patrick Boisseau, the newly launched Innovative Health Initiative is a real “game changer.” In this interview, he explains how companies should get involved in cross-sectoral medtech/pharma projects that will revolutionize European healthcare innovation.Informa
 
Loading …

Короткий довідник

Google login Twitter login Classic login